Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jason Velasco"'
Autor:
Daniel Y Zhu, Matthew J Gorman, Dansu Yuan, Jingyou Yu, Noe B Mercado, Katherine McMahan, Erica N Borducchi, Michelle Lifton, Jinyan Liu, Felix Nampanya, Shivani Patel, Lauren Peter, Lisa H Tostanoski, Laurent Pessaint, Alex Van Ry, Brad Finneyfrock, Jason Velasco, Elyse Teow, Renita Brown, Anthony Cook, Hanne Andersen, Mark G Lewis, Douglas A Lauffenburger, Dan H Barouch, Galit Alter
Publikováno v:
PLoS Biology, Vol 20, Iss 5, p e3001609 (2022)
Despite the rapid creation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines, the precise correlates of immunity against severe Coronavirus Disease 2019 (COVID-19) are still unknown. Neutralizing antibodies represent a robust s
Externí odkaz:
https://doaj.org/article/4d1be3554a1648f7a95b8e4694bcb0af
Autor:
Yongjun Sui, Jianping Li, Roushu Zhang, Sunaina Kiran Prabhu, Hanne Andersen, David Venzon, Anthony Cook, Renita Brown, Elyse Teow, Jason Velasco, Jack Greenhouse, Tammy Putman-Taylor, Tracey-Ann Campbell, Laurent Pessaint, Ian N. Moore, Laurel Lagenaur, Jim Talton, Matthew W. Breed, Josh Kramer, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Mark G. Lewis, Lai-Xi Wang, Jay A. Berzofsky
Publikováno v:
JCI Insight, Vol 6, Iss 10 (2021)
Effective SARS-CoV-2 vaccines are urgently needed. Although most vaccine strategies have focused on systemic immunization, here we compared the protective efficacy of 2 adjuvanted subunit vaccines with spike protein S1: an intramuscularly primed/boos
Externí odkaz:
https://doaj.org/article/d56cb415c28b4c54afc3a16c9c73cf2f
Autor:
Yongjun Sui, Jianping Li, Hanne Andersen, Roushu Zhang, Sunaina K Prabhu, Tanya Hoang, David Venzon, Anthony Cook, Renita Brown, Elyse Teow, Jason Velasco, Laurent Pessaint, Ian N Moore, Laurel Lagenaur, Jim Talton, Matthew W Breed, Josh Kramer, Kevin W Bock, Mahnaz Minai, Bianca M Nagata, Hyoyoung Choo-Wosoba, Mark G Lewis, Lai-Xi Wang, Jay A Berzofsky
Publikováno v:
PNAS Nexus
Emergence of SARS-CoV-2 variants and waning of vaccine/infection-induced immunity pose threats to curbing the COVID-19 pandemic. Effective, safe, and convenient booster vaccines are in need. We hypothesized that a variant-modified mucosal booster vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::960fc54cd9ba01760b82b16b9fb1555a
https://europepmc.org/articles/PMC9295201/
https://europepmc.org/articles/PMC9295201/
Autor:
Neil C. Dalvie, Lisa H. Tostanoski, Sergio A. Rodriguez-Aponte, Kawaljit Kaur, Sakshi Bajoria, Ozan S. Kumru, Amanda J. Martinot, Abishek Chandrashekar, Katherine McMahan, Noe B. Mercado, Jingyou Yu, Aiquan Chang, Victoria M. Giffin, Felix Nampanya, Shivani Patel, Lesley Bowman, Christopher A. Naranjo, Dongsoo Yun, Zach Flinchbaugh, Laurent Pessaint, Renita Brown, Jason Velasco, Elyse Teow, Anthony Cook, Hanne Andersen, Mark G. Lewis, Danielle L. Camp, Judith Maxwell Silverman, Gaurav S. Nagar, Harish D. Rao, Rakesh R. Lothe, Rahul Chandrasekharan, Meghraj P. Rajurkar, Umesh S. Shaligram, Harry Kleanthous, Sangeeta B. Joshi, David B. Volkin, Sumi Biswas, J. Christopher Love, Dan H. Barouch
Publikováno v:
Science advances. 8(11)
Authorized vaccines against SARS-CoV-2 remain less available in low- and middle-income countries due to insufficient supply, high costs, and storage requirements. Global immunity could still benefit from new vaccines using widely available, safe adju
Autor:
Abishek Chandrashekar, Jingyou Yu, Katherine McMahan, Catherine Jacob-Dolan, Jinyan Liu, Xuan He, David Hope, Tochi Anioke, Julia Barrett, Benjamin Chung, Nicole P. Hachmann, Michelle Lifton, Jessica Miller, Olivia Powers, Michaela Sciacca, Daniel Sellers, Mazuba Siamatu, Nehalee Surve, Haley VanWyk, Huahua Wan, Cindy Wu, Laurent Pessaint, Daniel Valentin, Alex Van Ry, Jeanne Muench, Mona Boursiquot, Anthony Cook, Jason Velasco, Elyse Teow, Adrianus C.M. Boon, Mehul S. Suthar, Neharika Jain, Amanda J. Martinot, Mark G. Lewis, Hanne Andersen, Dan H. Barouch
Publikováno v:
bioRxiv
BackgroundThe rapid spread of the SARS-CoV-2 Omicron (B.1.1.529) variant, including in highly vaccinated populations, has raised important questions about the efficacy of current vaccines. Immune correlates of vaccine protection against Omicron are n
Autor:
Caroline Subra, Natalie D. Collins, Christian Hofer, Jinyan Liu, Elyse Teow, Noe B. Mercado, Victoria M. Giffin, Laurent Pessaint, Hanne Andersen, Erica K. Barkei, Tochi Anioke, Jingyou Yu, Hannah A.D. King, Donald S. Burke, Dan H. Barouch, Anthony L. Cook, Julia Barrett, Kayvon Modjarrad, Diane Bolton, Katherine McMahan, David L. Hope, Jason Velasco, Huahua Wan, Sarah Gardner, Daniel Sellers, Nelson L. Michael, Alex Van Ry, Mark G. Lewis, Felix Nampanya, Abishek Chandrashekar, Aiquan Chang
Publikováno v:
Journal of virology. 96(2)
Live oral vaccines have been explored for their protective efficacy against respiratory viruses, particularly for adenovirus serotypes 4 and 7. The potential of a live oral vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
Autor:
Daniel Y. Zhu, Matthew J. Gorman, Dansu Yuan, Jingyou Yu, Noe B. Mercado, Katherine McMahan, Erica N. Borducchi, Michelle Lifton, Jinyan Liu, Felix Nampanya, Shivani Patel, Lauren Peter, Lisa H. Tostanoski, Laurent Pessaint, Alex Van Ry, Brad Finneyfrock, Jason Velasco, Elyse Teow, Renita Brown, Anthony Cook, Hanne Andersen, Mark G. Lewis, Douglas A. Lauffenburger, Dan H. Barouch, Galit Alter
Publikováno v:
PLoS biology. 20(5)
Despite the rapid creation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines, the precise correlates of immunity against severe Coronavirus Disease 2019 (COVID-19) are still unknown. Neutralizing antibodies represent a robust s
Autor:
Sangeeta B. Joshi, Jingyou Yu, Lisa H. Tostanoski, Christopher A Naranjo, Amanda J. Martinot, J. Christopher Love, Sumi Biswas, Jason Velasco, Judith M. Silverman, Harry Kleanthous, Neil C. Dalvie, Elyse Teow, Kawaljit Kaur, Felix Nampanya, Dongsoo Yun, Sergio A. Rodriguez-Aponte, Shivani A. Patel, David B. Volkin, Sakshi Bajoria, Lesley Bowman, Anthony L. Cook, Mark G. Lewis, Aiquan Chang, Dan H. Barouch, Abishek Chandrashekar, Ozan S. Kumru, Danielle L Camp, Zach Flinchbaugh, Renita Brown, Katherine McMahan, Laurent Pessaint, Hanne Leth Andersen, Noe B. Mercado, Victoria M. Giffin
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Vaccines against SARS-CoV-2 have been distributed at massive scale in developed countries, and have been effective at preventing COVID-19. Access to vaccines is limited, however, in low- and middle-income countries (LMICs) due to insufficient supply,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21262442c3432ab8bbd4719f6af0cd74
https://doi.org/10.1101/2021.07.13.452251
https://doi.org/10.1101/2021.07.13.452251
Autor:
Roushu Zhang, Jason Velasco, Lai-Xi Wang, Jack Greenhouse, Laurent Pessaint, Kevin W. Bock, Bianca M. Nagata, Mahnaz Minai, Renita Brown, Jay A. Berzofsky, Yongjun Sui, Tammy Putman-Taylor, Hanne Leth Andersen, Mark G. Lewis, Jianping Li, David Venzon, Laurel A. Lagenaur, Ian N. Moore, Elyse Teow, Sunaina Kiran Prabhu, Matthew Breed, Josh Kramer, Jim Talton, Tracey-Ann Campbell, Anthony L. Cook
Publikováno v:
JCI Insight
Effective SARS-CoV-2 vaccines are urgently needed. Although most vaccine strategies have focused on systemic immunization, here we compared the protective efficacy of 2 adjuvanted subunit vaccines with spike protein S1: an intramuscularly primed/boos
Autor:
Leslie van der Fits, Shivani A. Patel, Frank Wegmann, Sietske K. Rosendahl Huber, Katherine McMahan, Marjolein van Heerden, Jingyou Yu, Sarah Ducat, Cesar Piedra-Mora, Elyse Teow, Roland Zahn, Renita Brown, Brad Finneyfrock, Michelle A. Lifton, Laurent Pessaint, Dan H. Barouch, Erica N. Borducchi, Anthony L. Cook, Jason Velasco, Lauren Peter, Abishek Chandrashekar, Hanne Leth Andersen, Felix Nampanya, Noe B. Mercado, Mark G. Lewis, Ronnie Chamanza, Amanda J. Martinot, Xuan He, Lisa H. Tostanoski, Hanneke Schuitemaker, Alex Van Ry, Sidney Beecy, Jinyan Liu
Publikováno v:
bioRxiv
Cell
Cell
We previously reported that a single immunization with an adenovirus serotype 26 (Ad26) vector-based vaccine expressing an optimized SARS-CoV-2 spike (Ad26.COV2.S) protected rhesus macaques against SARS-CoV-2 challenge. To evaluate reduced doses of A